Rachel Haurwitz

Rachel Elizabeth Haurwitz (born May 20, 1985) is an American biochemist and structural biologist.

She is the co-founder, chief executive officer, and president of Caribou Biosciences, a genome editing company.

Haurwitz was born on May 20, 1985.

She grew up in Austin, Texas.

Her mother is an elementary school teacher and her father, an environmental journalist.

Haurwitz began researching RNA during her undergraduate years.

She attended Harvard College where she earned an undergraduate degree.

In 2007, she began doctoral studies at University of California, Berkeley.

At the age of 21, Haurwitz began working as a graduate student in Jennifer Doudna's laboratory, in 2008 where she completed her doctorate in molecular and cell biology.

Haurwitz originally intended on becoming an intellectual property lawyer for biotechnology patents but later chose to continue in science.

In 2011, Haurwitz and Doudna co-founded Caribou Biosciences, a gene editing spinout-startup company.

Haurwitz is the company's CEO and president.

She holds several patents for CRISPR-based technologies.

The firm was initially housed in the basement of the building that housed Doudna's laboratory.

The company supports the commercialization of CRISPR technology in healthcare and agriculture.

Its researchers explore issues in antimicrobial resistance, food scarcity, and vaccine shortages.

The company licensed Berkeley's CRISPR patent and deals with agricultural and pharmaceutical companies and research firms.

In 2018, Haurwitz announced that the firm was shifting focus on medicine and developing cancer therapies targeting microbes.

She is a long-distance runner and is training for a marathon.

Haurwitz knits as a hobby.

In 2021, Haurwitz was selected as a Bloomberg New Economy Catalyst.

As part of the program, she attended the annual New Economy Forum held in Singapore, and the Bloomberg New Economy Catalyst Retreat that same year.